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Leukocyte migration across human peritoneal mesothelial cells is
dependent on directed chemokine secretion and ICAM-1 expres-
sion.
Background. Leukocyte migration into the peritoneal cavity is a
diagnostic feature of peritonitis in patients treated with peritoneal
dialysis (PD). While neutrophil (PMN) influx is characteristic of
the acute phase of peritoneal infection, significant mononuclear
cell (MNC) infiltration, occurs throughout the whole period of
infection. Recent data suggests that human peritoneal mesothelial
cell (HPMC) adhesion molecule expression and the synthesis of
chemotactic cytokines may be important in the process.
Methods. In the present study we have examined, the regulation
and directed secretion of chemokines (IL-8, MCP-1 and RANTES)
and the basolateral to apical migration of unstimulated leukocytes
across mesothelial cell monolayers using an in vitro model where
HPMC were grown on the porous membrane of tissue culture
inserts. Separate experiments have defined the importance of
chemokine synthesis and ICAM-1 expression in the transmigra-
tion process.
Results. Apical stimulation of HPMC with IL-1b or TNFa
resulted in a time and dose dependent up-regulation of IL-8,
MCP-1 and RANTES mRNA expression and synthesis. This
secretion was predominately into the apical compartment
(.85%) with all chemokines. Apical pre-stimulation of HPMC
resulted in a dose- and time-dependent migration of both PMN
and MNC across HPMC. Neutrophil migration was significantly
reduced in the presence of appropriate concentrations of poly-
clonal IL-8 antibody (IL-1b (100 pg/ml) 153 6 12 versus anti-IL-8
(100 ng/ml) 71 6 7 (3 103) PMN, N 5 6, P , 0.02) and in the
presence of anti-ICAM-1 F(ab)92 fragments or soluble ICAM-1.
Constitutive and cytokine stimulated mononuclear cell migration
was significantly reduced in the simultaneous presence of poly-
clonal MCP-1 or RANTES antibody.
Conclusions. These data demonstrate that HPMC synthesize
IL-8, MCP-1 and RANTES in response to inflammatory cyto-
kines. HPMC-derived C-x-C and C-C chemokines might contrib-
ute to the intra-peritoneal recruitment of leukocytes during
peritoneal inflammation.
Leukocyte influx into the peritoneal cavity is a charac-
teristic and diagnostic feature of peritoneal infection, the
major infectious complication in patients treated for end-
stage renal disease with peritoneal dialysis (PD) [1]. The
peritoneal cavity normally contains a variable number of
macrophages and it is assumed that these cells, together
with the mesothelial cells that line the parietal and visceral
peritoneum, control the host’s responses to peritoneal
infection [2, 3].
Leukocyte influx following peritoneal infection is char-
acterized by increases in both polymorphonuclear leuko-
cytes (PMN) and mononuclear cells [mononuclear phago-
cytes (MNC) and lymphocytes] [1, 4, 5]. Initially PMN
predominate and they are subsequently replaced by mono-
nuclear cells as the main cell population as infection
resolves [1].
Over the past few years our understanding of the mech-
anisms by which leukocytes are recruited from the circula-
tion across the sub-mesothelial interstitium and into the
peritoneal cavity have increased from both ex vivo and in
vitro observations. In vitro studies have identified the ability
of mesothelial cells to secrete chemotactic cytokines fol-
lowing activation with pro-inflammatory cytokines or fol-
lowing activation with live bacteria or their secreted prod-
ucts [6–9]. In addition, using mesothelial cells grown on
porous supports, it has been demonstrated that the secre-
tion of interleukin-8 (IL-8) occurs in a directed manner
such that a gradient of chemotactic activity is generated
across the cells [10]. In addition to the secretion of chemo-
kines, the expression of adhesion molecules on the surface
of mesothelial cells appears to be important in the process
of leukocyte (PMN, mononuclear phagocytes and lympho-
cytes) attachment and migration [7, 8, 11–15].
Chemokines are a superfamily of cytokines structurally
characterized by four conserved cysteine residues in their
amino acid sequence. Two subfamilies can be distinguished
according to the position of the first two cysteines, which
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are either separated by one amino acid (C-X-C chemo-
kines) or are adjacent (C-C chemokines). IL-8, a prototype
C-X-C chemokine, has more specific action on neutrophils
while MCP-1 [16–19] and RANTES [20], both C-C chemo-
kines, are involved in the recruitment of mononuclear cells.
In addition to chemokine secretion, the expression of
adhesion molecules on the mesothelial cell surface
(counter-receptors for leukocyte integrins) have been iden-
tified as being important in the recruitment of leukocytes
[21]. In this respect the expression on functional ICAM-1
and VCAM-1 have been identified on peritoneal mesothe-
lial cells, and their importance in the attachment of differ-
ent leukocyte sub-populations demonstrated [12, 13, 15].
Ex vivo measurements of chemokine levels in dialysis
effluent have confirmed the importance of local IL-8,
human melanoma growth-stimulating activity (huGROa;
chemokines with specific activity for PMN) and MCP-1
secretion in the recruitment of leukocytes during peritonitis
and stable PD [1, 22–24]. The measured levels of these
leukocyte subset-specific chemotactic cytokines correlated
directly with the numbers of PMN and mononuclear cells in
the peritoneal cavity.
While these studies have identified the importance of
chemokine secretion and adhesion molecule expression by
mesothelial cells in the recruitment of leukocytes into the
peritoneal cavity, the precise cellular signaling mechanisms
controlling the transmigration of leukocytes across the
mesothelium have not been fully characterized. In the
present study, we have examined the synthesis of both the
PMN and mononuclear cell-specific chemokines (IL-8,
MCP-1 and RANTES) from cultured human peritoneal
mesothelial cells and examined their regulation at mRNA
and protein levels in response to the macrophage-derived
inflammatory cytokines IL-1b and tumor necrosis factor-a
(TNFa). Using an in vitro model using cells cultured on
polycarbonate membrane of cell culture inserts we have
characterized the importance of directed chemokine secre-
tion and ICAM-1 expression in the migration of leukocytes
across mesothelium. Our data demonstrate that the migra-
tion of leukocytes across mesothelium is primarily depen-
dent on the creation of a specific chemokine gradient
across the mesothelium, and secondarily on the up-regula-
tion of ICAM-1 expression on the mesothelial cell surface.
These data provide additional evidence of the role of the
mesothelium in the control of peritoneal inflammatory
processes.
METHODS
All chemicals, unless otherwise stated, were obtained
from the Sigma Aldrich Ltd. (Poole, Dorset, UK). All
tissue culture plastics were obtained from Becton Dickin-
son Ltd. (Oxford, UK). Recombinant human IL-1b was
purchased from R&D Systems (Newbury, UK). Human
TNFa was from BASF AG (Ludwigshafen, Germany). Its
specific activity was 8 3 107 U/mg protein (as assessed in a
48 hr L929 bioassay in the absence of actinomycin D).
Recombinant human IL-8, MCP-1 and RANTES were
from the National Institute of Biological Standards and
Control (NIBSC; Potters Bar, UK). Polyclonal anti-IL-8
antibody was supplied by NIBSC. Anti-human MCP-1
antibody was as previously described [25]. Goat polyclonal
anti-RANTES antibody was purchased from R&D Sys-
tems. All cytokine preparations were batched and stored at
270°C and freshly thawed for each experiment.
Isolation and culture of human peritoneal mesothelial
cells
Human peritoneal mesothelial cells (HPMC) were ob-
tained from the omental tissue of consenting patients
undergoing elective abdominal surgery as previously de-
scribed [7, 26–28]. The cells were isolated and character-
ized essentially as described previously [29]. Cells were
maintained in Earle’s buffered Medium 199 (Life Technol-
ogies Ltd., Paisley, UK) supplemented with penicillin (100
U/ml), streptomycin (100 mg/ml), L-glutamine (2 mM; Life
Technologies), transferrin (5 mg/ml), insulin (5 mg/ml),
hydrocortisone (0.4 mg/ml; all from Sigma) and 10% vol/vol
fetal calf serum (FCS) (Hyclone Ltd., North Shields, UK).
HPMC cultures were incubated at 37°C in a humidified 5%
CO2 atmosphere.
First passage HPMC in 75 cm3 flasks were passaged into
multiwell plates or insert cultures using a trypsin:EDTA:
glucose solution (0.125%:0.01%:0.1% wt/vol). All data
presented are from experiments performed with cells from
the second passage which had previously been growth
arrested as described below.
Establishment of HPMC monolayer cultures
For assessment of chemokine synthesis HPMC mono-
layer cultures were established in 6 or 24 well plates
(Falcon, Becton Dickinson, UK) as previously described [7,
28, 30].
Establishment of HPMC on tissue culture inserts
For assessment of directed secretion of chemokines and
transmigration of leukocytes confluent HPMC were sub-
cultured and seeded onto the bottom side of polycarbonate
tissue culture inserts (1 mm and 3 mm pore size; Falcon).
The inserts had previously been incubated with 100 ml of
100 mg/ml Type IV collagen (in 0.1% acetic acid; Sigma-
Aldrich Ltd.) for 60 minutes at room temperature and
washed (33) with phosphate-buffered saline (PBS) pH 7.4
(Life Technologies Ltd.). Preliminary experiments estab-
lished the seeding density (5 3 105/ml) and volume (200 ml)
necessary to obtain a confluent monolayer after 5 to 10
days. In the inverted position the cells were allowed to
attach for four hours at 37°C, prior to inversion into 24 well
plates containing complete medium and 10% vol/vol FCS.
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Assessment of monolayer integrity
To confirm that the HPMC layer was confluent the
following measurements were performed:
(a) assessment of the passage of radiolabeled albumin
125I-BSA). In apparently confluent HPMC insert cultures,
125I-BSA (106 dpm; ICN Biomedicals, High Wycombe,
UK) was added to the basolateral compartment and its
passage across the culture was monitored over six hours by
periodic sampling of the apical supernatant and counting in
a Gamma counter (LKB 1261; LKB-Wallac, Turku, Fin-
land). That the measured radioactivity remained attached
to the BSA was confirmed by 5% TCA precipitation,
SDS-PAGE electrophoresis (12% gel) and autoradiogra-
phy (data not shown). There was a direct and inverse
correlation between the percent passage of 125I-BSA and
the number of HPMC on the inserts (assessed by direct cell
counting after removal by trypsin/EDTA; r 5 0.534, P ,
0.001, N 5 54) and an inverse correlation between 125I-BSA
passage and electrical resistance across the insert (r 5 0.70,
P , 0.001, N 5 60; data from 6 experiments). In an initial
series of five experiments the passage of 125I-BSA was
assessed prior to, during and after the transmigration of
PMN across the insert cultures. After seeding and growth
arrest 4.2 6 0.5% of 125I-BSA traversed the insert, after a
60 minute migration, this increased to 9.6 6 0.9% (N 5 5,
P , 0.05 vs. post-growth arrest). Twenty-four hours later
after carefully washing the inserts free of PMN the amount
of 125I-BSA crossing the insert was 4.1 6 0.6% (N 5 5, P ,
0.05 vs. during migration.
(b) Measurement of electrical resistance across the mono-
layer. Electrical resistance was measured using a Millipore
resistance meter (Minicell ERS; Millipore Inc., Bedford,
MA, USA). All data were corrected for the resistance
measurements across blank collagen coated inserts. Follow-
ing establishment of insert cultures, the transmesothelial
electrical resistance was monitored on a daily basis until
confluence was achieved [31, 32]. There was a time depen-
dent increase in electrical resistance that reached a plateau
between 12 and 24 hours and thereafter gradually increased
over the succeeding 5 to 9 days (Fig. 1). There was a direct
correlation between transcellular electrical resistance and
the number of HPMC on the insert (r 5 0.730, P , 0.001,
N 5 42; data from 6 experiments). There was a direct
inverse correlation between the percent change in electrical
resistance across the insert and the number of PMN
transmigrating across it (r 5 0.463, P , 0.001, N 5 54
measurements).
(c) Light and transmission electron microscopy of sectioned
inserts. At various time points, the polycarbonate filter was
removed from its support and post-fixed (2 hr) in 2%
osmium tetroxide (Taab Laboratories, Reading, UK) and
desiccated in graded ethanol solutions, infiltrated with 50%
epon (Taab Laboratories) and embedded [33]. Thin sec-
tions (800 nm) were sectioned, stained with 2% uranyl
acetate (30 min) and 20% lead acetate (5 min), and viewed
in a Phillips CM12 transmission electron microscope (Phil-
lips Ltd., Cambridge, UK) at 80 kV.
For light microscopy, inserts were fixed in 2.5% gluter-
aldehyde in phosphate buffer pH 7.4, embedded in LR
white, sectioned (0.5 m sections) and stained with toluidine
blue as previously described [33]. Light and transmission
electron microscopy revealed that, while short-term (1 to 3
days) cultures HPMC occupied only one side of the poly-
carbonate filter, increasing the culture time was associated
with cells migrating through the pores in the insert (Fig.
2B). In short-term cultures this migration of HPMC did not
result in the dissipation of the chemokine gradient across
the cells (see later), but did reduce its magnitude in
comparison with later experiments where the use of a
collagen plug in the top of the well (5 mg/ml rat type I/III
collagen [34]) and serum free conditions below the mono-
layer resulted in a true monolayer of HPMC being formed
on one side of the insert (Fig. 2A).
Growth arrest of HPMC
Once monolayer or insert cultures had reached conflu-
ence they were transferred to medium containing 0.1%
vol/vol FCS for 48 hours prior to experiments. Under these
conditions the HPMC remained in a nonproliferative,
viable condition (as assessed by maintenance of cellular
ATP levels) for up to 96 hours [30].
Induction of IL-8, MCP-1 and RANTES by HPMC
Growth-arrested HPMC monolayer cultures were
washed four times with rest medium, and then incubated at
37°C in the presence or absence of the appropriate cytokine
to be tested. At specific time intervals, supernatants were
removed, centrifuged at 12,000 3 g, and then stored at
270°C until assayed for chemokine synthesis.
Chemokine production was induced in HPMC insert
cultures by the addition of IL-1b and TNFa to the apical
Fig. 1. Time dependent changes in electrical resistance across HPMC
insert cultures. Data are presented as Ohm/cm2 and are the mean (6 SEM)
from 6 experiments with cells from different donors (54 separate insert
cultures). Electrical resistance was corrected by subtracting that measured
across identical collagen coated inserts containing no HPMC.
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side of the culture. All medium was refreshed before the
stimulation. After 18 hours, a sample from both apical and
basolateral compartments were taken and assayed for
IL-8, MCP-1 and RANTES. At the end of the incubation
period the cell monolayers were washed with PBS, pH
7.3 (Life Technologies Ltd.), and trypsinized for cell
counting. Total the cell protein was estimated using the
modified Bradford method [35] in solubilized cell pellets
(0.1 N NaOH).
Cytokine synthesis measurements
IL-8 synthesis was measured in the culture supernatants
of control and stimulated HPMC by sandwich ELISA using
antibody pairs purchased from R&D Systems. MCP-1
synthesis was measured using a previously characterized
ELISA [25]. RANTES was assayed using commercial
RANTES - EASIA supplied by Medgenix SA, Fleurus,
Belgium.
RNA isolation, reverse transcription and polymerase
chain reaction amplification
HPMC were grown to confluence in 6 well plates (Fal-
con, Becton-Dickinson Ltd.), growth arrested as previously
described and exposed to control medium, IL-1b, TNFa
(all containing 0.1% FCS) for defined time periods up to 48
hours at 37°C. Total cellular RNA was extracted from both
control and cytokine treated HPMC following lysis with 4 M
guanidine isothiocyanate and centrifugation through 5.7 M
cesium chloride in 0.1 M EDTA [36]. Total RNA was
reverse transcribed into cDNA with M-MLVy reverse
transcriptase (Life Technologies Ltd.), using the random
hexamers method as previously described [30, 37]. The
PCR protocol was as follows: first cycle, 94°C for three
minutes, 55°C for one minute, 72°C for one minute; second
to 30th cycles, 94°C for 40 seconds, 55°C for one minute,
72°C for one minute. The final cycle was 94°C for one
minute and 60°C for 10 minutes. Polymerase chain reaction
(PCR) was performed for various cycles [25–30]. One-tenth
of the PCR reaction from both test (MCP-1 or RANTES)
and control (a-actin) product were mixed and separated by
flat bed electrophoresis in 1.5% wt/vol NuSieve GTG
agarose gels (Flowgen Instruments Ltd., Sittingbourne,
UK), stained with ethidium bromide (Sigma) and photo-
graphed. The negatives were scanned using a densitometer
(Model 620 video densitometer; Bio-Rad Laboratories
Ltd.) and the density of the bands compared to those of the
housekeeping gene.
Preparation of polymorphonuclear leukocytes
Polymorphonuclear leukocytes (PMN) were obtained
from the citrated venous blood of healthy laboratory vol-
unteers as previously detailed [15]. The isolated cells were
.98% PMN as assessed by morphological assessment of
Neat stained (Guest Medical, Sevenoaks, UK) cytospin
preparations.
Fig. 2. Light microscopic observation of human peritoneal mesangial
cells (HPMC) cultured on 3 mm pore size inserts stained with toluidine
blue. (A) HPMC cultured for 7 days on inserts in which the basolateral
side of the insert was coated with a 5 mg/ml collagen plug and maintained
in serum free conditions. (B) HPMC cultured for seven days on collagen
coated inserts. (C) HPMC cultured for 14 days on collagen coated inserts.
Table 1. The sequences of the amplification primers
Gene Primers Location
Size/
Ref
MCP-1 F-59-TCGCCTCCAGCATGAAAGTCT-39 73-79 369 bp
R-59-TCGCCTCCAGCATGAAAGTCT-39 539-559 [16]
RANTES F-59-ACGCCTCGCTGTCATCCTCAT-39 44-64 219 bp
R-59-TTCTTCTCTGGGTTGGCACAC-39 242-262 [38]
a-Actin F-59-GGAGCAATGATCTTGATCTT-39 11-31 204 bp
R-59-CCTTCCTGGCATGGAGTCCT-39 193-213 [39]
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Preparation of mononuclear cells
Mononuclear cells (MNC) were obtained from the ci-
trated venous blood of healthy human donors by dextran
sedimentation and Ficoll-Hypaque density gradient centrif-
ugation as previously described [40].
Leukocyte transmigration experiments
Preliminary experiments determined both the time
courses and the appropriate number of PMN and MNC to
add to the upper chamber (basolateral aspect) of the
HPMC insert cultures. Cytospin preparations were used to
confirm that the measured increase in transmigrated cells
were due to PMN or MNC and that significant damage to
the mesothelial monolayer did not occur during the exper-
iments (data not shown). Growth arrested HPMC insert
cultures were pre-incubated with (apically applied) doses of
IL-1b or TNFa for 18 hours prior to the addition of PMN
(2 3 106) or MNC (1 3 106). PMN transmigration exper-
iments were performed over a two hour period at 37°C and
MNC migration experiments for six hours at 37°C. In
separate experiments, prior to the addition of leukocytes,
defined concentrations of anti-chemokine antibodies,
ICAM-1 F(ab)92 fragments or recombinant soluble ICAM
(sICAM) (both supplied by Dr. Robert Rothlein) [41] were
added to either the lower (apical) or both the lower and
upper compartments prior to adding the leukocytes. Addi-
tional experiments used defined doses of recombinant
human IL-8, MCP-1 and RANTES added to the lower well
(apical) before transmigration assays.
Quantitation of transmigrated PMN and MNC
PMN transmigration across HPMC was assessed in su-
pernatants isolated from the apical aspect of the cells by
direct cell counting (Coulter ZM, Coulter Electronics,
Luton, UK) and by assessment of PMN myeloperoxidase
activity [15]. Briefly, after centrifugation of 500 ml of apical
supernatant, the PMN pellet was lysed with 100 ml of 1%
vol/vol Triton-X-100, and serial dilutions prepared in a 96
well microtiterplate. One hundred microlitres of substrate
[2,299-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) 1
mg/ml in citrate-phosphate buffer pH 4.0] was added. After
5 to 10 minutes the color development was monitored at
410 nm. The number of PMN in the unknown sample was
calculated by comparison with the absorbance values ob-
tained from a standard curve prepared from defined num-
bers of PMN from the same donor. There was a direct
correlation between PMN number and absorbance at 410
nm (N 5 60, r 5 0.997, P , 0.0001).
For quantitation of MNC transmigration, after defined
incubation periods, the inserts were removed, 1 ml of 10
mM EDTA (Sigma) in PBS pH 7.3 (Life Technologies Ltd.)
was added to each well of the 24 well plate to detach
adhered mononuclear cell from the plastic. The medium in
the lower wells was thoroughly mixed, and aliquots taken
for counting of migrated MNC in a Coulter counter (Model
ZM; Coulter Electronics Ltd. UK). Cytospin analysis con-
firmed that .98% of the transmigrated cells were of
mononuclear cell origin.
Statistical analysis
All experiments were performed with HPMC prepared
from at least five different omental specimens. All statisti-
cal analyses were performed using the Wilcoxson matched-
pairs signed ranks test (Statview 5121; Apple Macintosh
Inc, Cupertino, CA, USA), a P value of less than 0.05 being
considered as significant. All data are presented as mean
(6 SEM).
RESULTS
Synthesis of chemokines by HPMC
Unstimulated growth-arrested HPMC cultured as mono-
layers on plastic released MCP-1 and RANTES. After 48
hours the MCP-1 release was 1101 6 442 and RANTES
release 11.0 6 2.7 (all expressed as pg/105 HPMC, mean 6
SEM, N 5 5). Stimulation of HPMC with IL-1b or TNFa
induced a dose (Fig. 3) and time-dependent generation of
both MCP-1 and RANTES (Fig. 4). These released levels
were significantly above controls at IL-1 doses above 100
pg/ml and TNFa doses above 1000 pg/ml for MCP-1 and
RANTES, respectively. At all cytokine doses and over the
whole time course (3 to 72 hr) the generation of MCP-1 was
greater than that of RANTES.
Directed secretion of IL-8, MCP-1 and RANTES by
HPMC
In insert HPMC cultures the constitutive and cytokine
driven secretion of IL-8, MCP-1 and RANTES occurred in
a directed manner, such that the highest levels were always
detected on the apical surface of the mesothelium. This
predominately apical directed secretion occurred even in
insert cultures where the mesothelial cells had migrated
through the 3 mm pores of the polycarbonate filter (Fig. 2B,
C). In these experiments (after an 18 hr stimulation period)
between 62.4% and 67.07% of chemokine secretion oc-
curred in the apical direction (Fig. 5A). If this migration of
HPMC was prevented either by culturing the cells on
smaller pore size inserts (0.4 mm) or by using a collagen
plug and serum free conditions on the basolateral side of
the membrane then between 83.2% and 92% of the che-
mokine synthesis occurred in an apical direction (Fig. 5B).
Induction of HPMC MCP-1 and RANTES mRNA
The HPMC total mRNA isolated from control and
cytokine-stimulated cells was reverse transcribed and am-
plified by PCR. These experiments demonstrated that
HPMC costitutively expressed specific transcripts of 369
and 219 base pairs for MCP-1 and RANTES respectively
(data not shown). Treatment of HPMC with IL-1b (or
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TNFa, data not shown) resulted in a time dependent
up-regulation in the expression of mRNA signal when
compared to the a-actin housekeeping gene transcripts
amplified from the same samples (Fig. 6). Temporally, the
steady state levels of MCP-1 mRNA preceded that of
RANTES mRNA.
Effect of transcription and translation inhibitors
Preincubation of HPMC with actinomycin-D (0.1 to 10
mg/ml) for 30 minutes at 37°C induced a dose-dependent
inhibition of both constitutive and IL-1b (100 pg/ml)
stimulated MCP-1 generation by HPMC. At 10 mg/ml
constitutive levels of MCP-1 were reduced from 832 6 253
to 581 6 181 (pg/105 HPMC; N 5 5, P , 0.05). In IL-1b
stimulated HPMC, MCP-1 levels were reduced from
5377 6 573 to 1065 6 362 (pg/105 HPMC; N 5 5, P , 0.05).
These levels represented 30.17% and 80.14% inhibition,
respectively. For RANTES generation, these inhibitory
effects were only significant in IL-1b stimulated HPMC
were its synthesis was reduced from 159 6 33 to 19.7 6 1.7
(pg/105 HPMC; N 5 5, P , 0.05).
Pre-incubation of HPMC with increasing (non-toxic as
evidenced by normal cellular ATP levels) doses of cyclo-
heximide (0 to 100 mg/ml) resulted in a reduction in
cytokine-driven but not constitutive MCP-1 and RANTES
production. At the highest concentration IL-1b-driven
MCP-1 and RANTES were reduced by means of 36.16%
and 59.53%, respectively (N 5 5, P , 0.05 vs. control for
both).
Effect of apical addition of IL-8, MCP-1 and RANTES of
PMN and MNC transmigration across unstimulated
HPMC
HPMC established on insert cultures were washed (35)
both apically and basolaterally to remove constitutively
secreted chemokines, subsequently recombinant IL-8,
MCP-1 or RANTES were added apically and the transmi-
gration assays were performed immediately. Apically added
IL-8 (10 to 100 ng/ml) induced a time and dose dependent
increase in PMN transmigration; At all doses, the increase
in migration above control was significant after 60 minutes,
and at the highest dose tested reached a plateau between
Fig. 3. Dose effect of increasing concentrations
of interleukin-1b (f; IL-1b; 0.1 to 1000 pg/ml)
or tumor necrosis factor a (M; TNFa; 1 to
10000 pg/ml) on the synthesis of (A) monocyte
chemotactic peptide-1 (MCP-1) and (B)
RANTES by growth arrested human peritoneal
mesothelial cells (HPMC) monolayer cultures.
Data are the mean (6 SEM) of 6 experiments
performed with HPMC isolated from different
donors. *Represents a significant increase
above control.
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60 and 120 minutes (Fig. 7A). In similar experiments,
apical addition of increasing concentrations of MCP-1 or
RANTES resulted in significant increases in the number of
MNC migrating across HPMC. In these experiments MNC
migration (after 6 hr) was significantly above control at
doses of MCP-1 above 50 pg/ml and doses of RANTES
above 1000 pg/ml (Fig. 7B).
Effect of IL-1b pre-stimulation of PMN and MNC
transmigration across HPMC
Apical pre-stimulation of HPMC monolayers with in-
creasing doses of IL-1b (18 hr) resulted in a dose- and
time-dependent increase in the migration of both PMN
from the basolateral to apical compartments compared to
the number of leukocytes migrating across unstimulated
HPMC. For PMN migration this migration was significantly
above control (for all doses of IL-1b) after 60 minutes and
continued to increase over the whole time course studied
(Fig. 8A). Apical pre-stimulation of HPMC insert cultures
with IL-1b (18 hr, 100 pg/ml) resulted in a time dependent
increase in MNC migration. This increase became signifi-
cant above control after six hours migration and continued
to increase over the whole time course studied (Fig. 8B).
Pre-incubation of IL-1b (100 pg/ml) stimulated HPMC
insert cultures with actinomycin D (10 mg/ml) or cyclohex-
imide (100 mg/ml) resulted in a reduction in the number
PMN crossing the insert compared to IL-1b stimulation
alone. After a two hour migration the number of PMN
traversing the insert was reduced from 92 6 6 (3 103)
following IL-1b stimulation to 45 6 6, and 31 6 3 following
actinomycin D or cycloheximide treatments, respectively
(N 5 5, P , 0.05 vs. IL-1b alone).
Effect of anti-IL-8 antibody and soluble ICAM-1 on
PMN migration across IL-1b pre-stimulated HPMC
Apical and basolateral addition of saturating concentra-
tions of antibody to IL-8 resulted in significant reduction in
neutrophil migration. At the highest concentration of poly-
clonal IL-8 antibody tested (100 ng/ml), PMN migration
was reduced by 89%. In IL-1b pre-stimulated HPMC PMN
migration was reduced from 160.7 6 31 to 74 6 18 (3 103)
after two hours in anti-IL-8 treated HPMC, (N 5 6, P ,
0.02). Control migration at this time point was 64 6 11.6 (3
103 PMN) (Fig. 9A).
Apical and basolateral addition of soluble ICAM (sI-
CAM; 0.1 to 10 ng/ml) to IL-1b pre-stimulated HPMC
significantly, and in a dose-dependent manner reduced
PMN migration (measured after 2 hr; Fig. 9B). At the
Fig. 4. Time course of (A) monocyte
chemotactic peptide-1 (MCP-1) and (B)
RANTES synthesis by growth arrested HPMC
monolayer cultures following treatment with
control medium (), IL-1b (M; 100 pg/ml) or
TNFa (E; 1000 pg/ml). Data presented are the
mean (6 SEM) of 6 experiments performed with
HPMC isolated from different donors.
*Represents a significant increase above
control.
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highest concentrations tested the levels were reduced to
those in the controls. In parallel experiments a similar
degree of inhibition of PMN migration was achieved using
anti-ICAM-1 F(ab)92 fragments (data not shown).
In separate experiments the sICAM (10 ng/ml) was
added either to the apical or to the basolateral aspect of the
IL-1b (100 pg/ml, 18 hr) insert cultures prior to PMN
migration assays. Under these conditions apical sICAM
addition resulted in an 86.37% inhibition of transmigration
and basolateral addition of sICAM resulted in a 41.6%
inhibition of migration, which can be compared with the
92.3% inhibition in experiments where sICAM was added
to both compartments (see above).
Effect of anti-MCP-1 and anti-RANTES antibodies on
MNC transmigration across IL-1b pre-stimulated
HPMC
Co-incubation of IL-1b pre-stimulated HPMC mono-
layer with antibodies to MCP-1 and RANTES added to
both apical and basolateral compartments resulted in an
inhibition of MNC transmigration only with antibodies to
MCP-1. At the highest antibody concentrations tested MNC
migration was reduced by 41% (N 5 6, P , 0.05; Fig. 10).
DISCUSSION
Peritonitis is still the major cause of treatment failure in
patients treated for end-stage renal failure with peritoneal
dialysis [42]. Leukocyte influx is a characteristic feature of
peritonitis and is important in the eradication of invading
microorganisms [4, 5]. Repeated peritoneal inflammation,
however, is associated with loss of peritoneal function,
which has led to an interest in understanding more about
the mechanisms by which peritoneal inflammatory pro-
cesses are initiated, amplified and resolved [3, 43, 44].
One of the early and diagnostic features of peritoneal
infection is the rapid influx of PMN into the peritoneal
cavity and these cells become the predominant peritoneal
leukocyte population for the first 12 to 24 hours of infection
[1]. During the same period, however, the number of
mononuclear cells (mononuclear phagocytes, PMØ and T
and B lymphocytes) increases and once the peak of PMN
influx is reached these cells become the largest leukocyte
population in the peritoneal cavity [1]. This latter phase of
leukocyte recruitment is thought to be critical in determin-
ing whether inflammation resolves [45].
Leukocyte infiltration into sites of inflammation is con-
trolled at a number of phases between, extravasation across
capillary endothelium at specific sites, traversing the inter-
stitium of the organ involved and arriving at the site of
infection [46]. While the mechanisms controlling the re-
cruitment, adherence and movement of leukocytes across
endothelium are relatively well defined, the mechanisms by
which they migrate into the peritoneal cavity are less well
understood. It is thought that signals generated during
intra-peritoneal inflammation result in the recruitment of
leukocytes from the peripheral circulation [1, 7, 8, 23].
These cells then extravasate across the microvascular en-
dothelium of the peritoneal membrane circulation, cross
the sub-mesothelial stroma and enter the peritoneal cavity
through mesothelial cell tight junctions. During this process
PMN and HPMC are in direct contact for at least a short
period of time [47].
Fig. 5. Directed secretion of IL-8, MCP-1 and RANTES in HPMC insert
cultures. (A) Data from five experiments with seven-day insert cultures
established in normal 3 mm pore size inserts where no attempt was made
to prevent HPMC migration through the inserts. Symbols are: (M) control
apical; (p) control basolateral; (f) IL-1b apical; (o) IL-1b basolateral.
(B) Data from six experiments from inserts where HPMC migration was
prevented by a basolateral collagen plug and serum free conditions.
Symbols are: (M) apical; (f) basolateral. Line or * represents a significant
difference (P , 0.05).
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Ex vivo data generated from the measurement of inflam-
matory mediators in spent dialysis effluent has been central
in our understanding of peritoneal inflammatory processes,
including the mechanisms by which leukocytes are re-
cruited into the peritoneum [5, 8, 23, 48, 49]. These data,
together with in vitro observations of chemokine produc-
tion and adhesion molecule expression by peritoneal me-
sothelial cells, have identified that these cells play an
important role in the leukocyte recruitment process [3, 7, 8,
10–12, 22–24, 50]. The precise mechanisms by which leu-
kocytes traverse the mesothelial monolayer, and the rela-
tive importance of chemokine synthesis and adhesion
molecule expression in recruiting leukocyte into the peri-
toneum have not been fully defined. In addition, those
factors controlling the switch in leukocyte phenotype dur-
ing peritoneal inflammation are poorly understood.
In the present study we have established a model in vitro
system in which cultured human peritoneal mesothelial
cells are established on porous inserts. This has allowed us
to define both the roles of specific and directed C-C and
Fig. 6. Transcription of MCP-1 and RANTES
induced following stimulation of HPMC with
IL-1b (100 pg/ml). (A) HPMC were incubated
from 15 minutes to 72 hours. The RNA was
extracted and PCR was performed with primers
specific for the MCP-1 gene (369 bp fragment),
RANTES gene (219 bp fragment) and a-actin
(204 bp fragment) as described in the Methods
section. A portion of the PCR for MCP-1,
RANTES and a-actin were mixed and
electrophoresed. Lane one is DNA molecular
weight standards. The products were
subsequently stained with ethidium bromide,
photographed (the negative of which is
presented), and compared to DNA standards.
(B) The (target gene/a-actin) densitometric
ratios obtained following scanning of the bands.
Data are presented as the fold increase in the
ratio of MCP-1 (f) and RANTES (u)/a-actin
compared to control expression from one
representative experiment of three performed
with HPMC isolated from different donors.
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C-x-C chemokine synthesis and the relative importance of
ICAM-1 expression in the movement of leukocytes across
mesothelium.
Previous studies have identified the mesothelium ex-
pressed chemokine mRNA and are a potent source of
chemokine synthesis [7, 8, 11]. In addition, in an insert
system similar to our own, Zeillemaker et al [10] confirmed
that the directed secretion of IL-8 controlled the direction
of PMN migration across mesothelium. We have confirmed
and extended these observations to include a characteriza-
tion of the importance of transcriptional and translational
activation of chemokine synthesis and their directed (po-
larized) secretion in the control of PMN and mononuclear
cell migration.
One feature of the insert culture system that we did
not anticipate initially, was the ability of the mesothelial
Fig. 7. Time and chemokine dose dependency
of PMN and MNC migration across HPMC
insert cultures. (A) PMN migration across
HPMC insert cultures in the presence of
apically added recombinant IL-8 (10-1000 ng/
ml). Data presented as mean (6 SEM) PMN
numbers from 6 experiments performed with
HPMC isolated from different donors.
*Represents a significant difference compared
to control migration. Symbols are: (f) control;
(F) 10 ng/ml; () 100 ng/ml; (M) 1000 ng/ml.
(B) MNC migration across HPMC insert
cultures in the presence of increasing doses of
recombinant human MCP-1 (50 to 5000 pg/ml)
or RANTES (100 to 10000 pg/ml). Symbols are:
(  ) MCP-1; (p) RANTES; (M) control. Thedata presented are the mean (6 SEM) MNC
transmigration from 5 separate experiments
with HPMC prepared from separate omental
specimens. *Represents a statistically significant
difference compared to control.
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cells to migrate through the 3 mm pores in the inserts.
Measurement of apical and basolateral chemokine secre-
tion in this system, nevertheless demonstrated that .65%
of the chemokine concentration was present in the apical
compartment. These data concur with the pattern of che-
mokine secretion presented in the Zeillemaker study [10].
One assumes therefore, that as no method was used to
prevent mesothelial cell migration and since the authors
used a larger pore size inserts (8 mm) that the process of
HPMC migration also occurred in these authors system.
In experiments where we established a true mesothelial
cell monolayer (as defined by light and electron microscopy
and resistance measurement), we observed an increase in
the polarity of secretion such that .80% of each chemo-
kine measured was secreted into the apical compartment.
These data suggest that, despite the migration of mesothe-
lial cells through the insert pores, a functional polarized
system is established within which questions regarding the
migration of leukocytes across mesothelium can be ad-
dressed. While much of the migration data presented
herein have used this system, our subsequent experiments
using the true monolayer system have confirmed the valid-
ity of these initial findings (Robson and Topley, unpub-
lished data).
The migration of both PMN and MNC across mesothe-
lial cells, established in insert cultures, was dependent on
the establishment of a chemokine gradient across the cells.
This effect was confirmed in experiments where the migra-
tion of PMN (from the basolateral to the apical direction)
was facilitated, in unstimulated washed inserts, by the
apical addition of recombinant IL-8, and was inhibited by
the simultaneous presence of specific antibody to IL-8. In
parallel experiments the migration of MNC across me-
sothelium was facilitated by apical addition of both recom-
binant MCP-1 and RANTES and was inhibited in pre-
stimulation experiments by antibodies directed against the
individual chemokines. In each case much greater concen-
trations of RANTES than MCP-1 were required to recruit
similar numbers of MNC.
Cytokine stimulation of HPMC monolayers resulted in
the up-regulation of MCP-1 and RANTES mRNA expres-
sion and secretion and parallel previous observations on
the induction of IL-8 synthesis [7, 8]. This induction of C-C
chemokine secretion was in each case inhibited by tran-
scriptional and translational inhibitors. These data suggest
that the observed increases in MCP-1 and RANTES were
at least partly dependent on de novo mRNA expression and
new protein synthesis in cytokine treated HPMC. The
magnitude and time courses of the secretion of these two
cytokines were, however, different such that MCP-1 was
induced more rapidly and secreted in greater concentra-
tions than RANTES. These data confirm previous obser-
vations made in human mesangial cells [51].
Pre-stimulation of HPMC insert cultures with IL-1b (or
TNFa) resulted in dose- and time-dependent increases in
the subsequent ability of both PMN and MNC to cross the
mesothelium from the basolateral to the apical compart-
ments. The time courses of migration, however, where
significantly different as PMN migration occurred over a
much shorter time course than MNC. Antibody blocking
experiments in cytokine pre-stimulated monolayers con-
firmed that dissipation of the HPMC-derived IL-8 gradient
was critical in the control of PMN efflux [10]. Antibody
Fig. 8. Migration of PMN and MNC across cytokine stimulated HPMC
insert cultures. (A) Time and dose effect of PMN migration across HPMC
insert cultures pre-stimulated (18 hr) with increasing doses of IL-1b. Data
presented are the mean (6 SEM) PMN numbers from 6 experiments
performed with HPMC isolated from different donors. Symbols are: (f)
control; (F) 0.1 pg/ml; () 10 pg/ml; (M) 100 pg/ml. (B) Time course of
MNC transmigration across HPMC monolayer pre-stimulated with IL-1b
(M; 100 pg/ml) for 18 hours as compared to control (E). Data are mean 6
SEM from 5 experiments, 3 cell inserts each, with HPMC prepared from
separate omental specimens. *Statistically significant difference compared
to unstimulated MNC transmigration at the same time point.
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blocking experiments also demonstrated the relative impor-
tance of HPMC secreted MCP-1 and RANTES gradients
in the process of MNC migration. While a significant
reduction in MNC migration was observed in the presence
of anti-MCP-1 antibody, anti-RANTES did not inhibit
MNC migration. This effect was not due to the efficacy of
this anti-RANTES antibody as control experiments dem-
onstrated its ability to inhibit the effects of added re-
combinant cytokine. The relative lack of importance of
RANTES in the process of migration of MNC across
Fig. 9. Effect of anti-IL-8 on PMN migration across HPMC insert cultures. (A) Effect of increasing concentrations of anti-IL-8 antibody (Ab1 and
Ab2) (added apically and basolaterally) on IL-1b driven PMN migration across HPMC insert cultures. Data presented are the mean (6 SEM) PMN
numbers from 6 experiments performed with HPMC isolated from separate omental specimens. Symbols are: (M) control; (f) IL-1b; (p) AB1; (o)
AB2. (B) Effect of increasing concentrations of soluble (sICAM; added apically and basolaterally) on IL-1b driven PMN migration across HPMC insert
cultures. Data presented are the mean (6 SEM) PMN numbers from 6 experiments performed with HPMC isolated from separate omental specimens.
Control contained 10 ng/ml sICAM.
Fig. 10. Inhibition of transmigration by anti-
MCP-1 and anti-RANTES antibodies. Effect of
anti-MCP-1 and anti-RANTES on MNC across
IL-1b pre-stimulated HPMC monolayer (18 hr).
Data are mean 6 SEM from 5 experiments, 3
cell inserts each, with HPMC prepared from
separate omental specimens. *Statistically
significant difference compared to MNC
transmigration across IL-1b pre-stimulated
HPMC. Symbols are: (f) no antibody; ( )
MCP-1 antibody; ( ) RANTES antibody; ( )
both antibodies; (M) control.
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mesothelium parallels ex vivo measurements of C-C che-
mokines in peritoneal effluent where its levels were unde-
tectable (or very low) during peritonitis [24].
Previous observations by ourselves and others have
demonstrated that HPMC express adhesion molecules of
the immunoglobulin superfamily (ICAM-1 and VCAM-
1/2) on their surface [13] [11, 12, 15]. The expression of
these adhesion proteins have been shown to be important
in PMN and MNC adherence to HPMC, respectively
[11–13, 15]. In the present study we have evaluated to what
extent ICAM-1 expression was important in controlling
PMN migration across HPMC. Soluble ICAM blocking
experiments confirmed that the expression of this adhesion
molecule was involved in the process. We have not identi-
fied the location of ICAM-1 on the surface of HPMC, our
blocking experiments, in which apical addition of sICAM
resulted in higher levels of inhibition of PMN migration
(than basolateral addition) suggest, however, that in this
model, ICAM-1 expression occurs predominantly on the
apical surface of the mesothelium and its expression con-
trols the adherence and migration of PMN [13, 14].
In the present study we have examined the importance of
directed chemokine secretion and adhesion molecule ex-
pression in the recruitment of specific leukocyte popula-
tions into the peritoneal cavity. Our data confirm and add
weight to the growing literature that the mesothelium plays
a central role in controlling leukocyte recruitment by the
modification of chemokine secretion and adhesion mole-
cule expression.
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APPENDIX
Abbreviations used in this article are: ELISA, enzyme linked immuno-
assay; FCS, fetal calf serum; HPMC, human peritoneal mesothelial cell;
huGROa, human melanoma growth-stimulating activity; ICAM-1, inter-
cellular adhesion molecule-1; IL-1b, interleukin-1b; IL-8, interleukin-8;
ICAM-1, intercellular adhesion molecule-1, MCP-1, monocyte chemotac-
tic peptide-1; PD, peritoneal dialysis; RANTES, regulated upon activation
normal T-cell expressed and secreted; RT-PCR, reverse transcription-
polymerase chain reaction; sICAM, soluble ICAM; TNFa, tumor necrosis
factor-a; VCAM-1, vascular cell adhesion molecule-1.
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